Preparation and evaluation of co processed excipient for development of pharmaceutical dosage form

Abstract

Excipients are a critical part of any pharmaceutical formulation. Their selection and concentration depends on their functionality/ role in the formulation. Excipients used in the pharmaceutical formulations are usually in high concentration and it is calculated through hit and trial method. Despite adding multiple excipients the final product have chances to lack in some or the other property like flowability, compressibility, stability and disintegration etc. newlineCo-processed excipient are the mixture of two and more conventional excipients that provides significant benefits over the individual excipients. Such multifunctional co-processed excipient is a single excipient that minimizes the number of excipients that are incorporated into tablets during the manufacturing process. newlineCo-processed excipients have enhanced functionality attributes required for developing tablet dosage forms. This is majorly applicable for the tablets manufactured through direct compression technology. The purpose of this study was to prepare and evaluate co-processed that can be used as a one stop solution for the seamless development of pharmaceutical dosage form. The study was broadly divided into two phases, Phase 1 included development of mannitol: microcrystalline cellulose: silicon dioxide based co-processed excipient through dry granulation technique and in Phase 2 same concentration of excipients were used to develop co-processed excipient by wet granulation technique. newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced